A 2018 pilot study by Patil-Bhole and colleagues measured trace gold in blood after administration of Swarnabhasma.
What was measured
The researchers collected blood samples over four hours in three healthy male participants. The study compared different administration conditions and reported measurable trace gold.
What remains unknown
The study did not test whether people experienced a clinical benefit. Its sample and follow-up period also limit what can be inferred about adverse effects, repeated use, or other formulations.
How to assess another study
Check the preparation, participant group, comparison group, outcome and follow-up. A result from one batch or formulation should be interpreted within that study’s design. Read the paper on PubMed.
Related reading
Safety and research overview · Safety considerations · Swarn Bhasma product overview